Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 2
2008 2
2009 1
2012 1
2013 1
2018 2
2019 3
2020 8
2021 4
2022 5
2023 5
2024 3
2025 8
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean e moseleyi (9 results)?
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.
Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, Stein F, Bretagne M, Ederhy S, Fenioux C, Hamwy O, Funck-Brentano E, Romano E, Pieroni L, Münster JP, Allenbach Y, Anquetil C, Leonard-Louis S, Palaskas NL, Hayek SS, Katus HA, Giannitsis E, Frey N, Kaya Z, Moslehi J, Prifti E, Salem JE. Lehmann LH, et al. Circulation. 2023 Aug 8;148(6):473-486. doi: 10.1161/CIRCULATIONAHA.123.062405. Epub 2023 Jun 15. Circulation. 2023. PMID: 37317858 Free PMC article.
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Tocchetti CG, et al. Eur J Heart Fail. 2024 Oct;26(10):2055-2076. doi: 10.1002/ejhf.3340. Epub 2024 Aug 1. Eur J Heart Fail. 2024. PMID: 39087551 Free article. Review.
The clinical efficacy of all these treatments generally outweighs the risks, but there is a high rate of immune-related adverse events (irAEs), which are often unpredictable in timing with clinical sequalae ranging from mild (e.g. rash) to severe or even fatal (e.g. …
The clinical efficacy of all these treatments generally outweighs the risks, but there is a high rate of immune-related adverse events (irAE …
Forward and reverse cardio-oncology.
Meijers WC, Aboumsallem JP, Lyon AR, Moslehi J, de Boer RA. Meijers WC, et al. Physiol Rev. 2026 Jan 1;106(1):587-644. doi: 10.1152/physrev.00041.2024. Epub 2025 Sep 22. Physiol Rev. 2026. PMID: 40983491 Free article. Review.
This raised the question of whether this phenomenon was due to shared risk factors (i.e. diabetes mellitus, obesity, etc.) between cardiovascular disease (CVD) and cancer or because of shared underlying mechanisms, and thus whether the presence of one of the two disease en …
This raised the question of whether this phenomenon was due to shared risk factors (i.e. diabetes mellitus, obesity, etc.) between ca …
CXCR6+ T Cells Drive Immune Checkpoint Inhibitor Myocarditis.
Munir AZ, Gutierrez A, Krawiec CJ, Manandhar P, Shyani AC, Ma P, Gougis P, Baylis RA, Hou L, Remold-O'Donnell E, Balko JM, Salem JE, Lavine KJ, Lichtman AH, Qin J, Moslehi JJ. Munir AZ, et al. Circulation. 2026 Jan 7:10.1161/CIRCULATIONAHA.125.076976. doi: 10.1161/CIRCULATIONAHA.125.076976. Online ahead of print. Circulation. 2026. PMID: 41498147 Free PMC article.
Circulating immune checkpoints predict heart failure outcomes.
Screever EM, Yousif LIE, Moslehi JJ, Salem JE, Voors AA, Silljé HHW, de Boer RA, Meijers WC. Screever EM, et al. ESC Heart Fail. 2023 Aug;10(4):2330-2337. doi: 10.1002/ehf2.14304. Epub 2023 Apr 25. ESC Heart Fail. 2023. PMID: 37186066 Free PMC article.
Based on this observation, serum levels of three well-known IC ligands (i.e. sPD-L1, sPD-L2 and galectin-9) were measured in stable HF patients from the Vitamin D Chronic Heart Failure (VitD-CHF) study (n = 101), as well as healthy individuals from the Prevention of Renal …
Based on this observation, serum levels of three well-known IC ligands (i.e. sPD-L1, sPD-L2 and galectin-9) were measured in stable H …
Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.
Ammirati E, Bizzi E, Veronese G, Groh M, Van de Heyning CM, Lehtonen J, Pineton de Chambrun M, Cereda A, Picchi C, Trotta L, Moslehi JJ, Brucato A. Ammirati E, et al. Front Med (Lausanne). 2022 Mar 7;9:838564. doi: 10.3389/fmed.2022.838564. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35350578 Free PMC article.
In acute myocarditis, recent data on the use of immunomodulating therapies have been reported both in the setting of systemic autoimmune disorders and in the setting of isolated forms, especially in patients with specific histology (e.g., eosinophilic myocarditis) or with …
In acute myocarditis, recent data on the use of immunomodulating therapies have been reported both in the setting of systemic autoimmune dis …
Reactivity of Fe(III)-containing pyrophosphate salts with phenolics: complexation, oxidation, and surface interaction.
Bijlsma J, Moslehi N, Velikov KP, Kegel WK, Vincken JP, de Bruijn WJC. Bijlsma J, et al. Food Chem. 2023 May 1;407:135156. doi: 10.1016/j.foodchem.2022.135156. Epub 2022 Dec 6. Food Chem. 2023. PMID: 36525808 Free article.
Mixed pyrophosphate salts with the general formula Ca(2(1-x))Fe(4x)(P(2)O(7))((1+2x)) potentially possess less iron-phenolic reactivity compared to ferric pyrophosphate (FePP), due to decreased soluble Fe in the food-relevant pH range 3-7. We investigated reactivity (i.e., …
Mixed pyrophosphate salts with the general formula Ca(2(1-x))Fe(4x)(P(2)O(7))((1+2x)) potentially possess less iron-phenolic reactivity comp …
43 results